Piper Sandler & Co’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-25,003
Closed -$257K – 15
2023
Q2
$257K Hold
25,003
– – 0.27% 14
2023
Q1
$253K Hold
25,003
– – 0.17% 22
2022
Q4
$248K Hold
25,003
– – 0.26% 21
2022
Q3
$243K Hold
25,003
– – 0.2% 26
2022
Q2
$242K Hold
25,003
– – 0.22% 28
2022
Q1
$244K Buy
+25,003
New +$241K 0.18% 19

Piper Sandler & Co's DALS Position: Q3 2023 in Review

Piper Sandler & Co sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q3 2023, closing a stake of 25,003 shares — an estimated $257K sold.

Piper Sandler & Co first reported a position in DALS in Q1 2022 and held it in 6 quarters. The position peaked at $257K in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • Piper Sandler & Co reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
  • Piper Sandler & Co sold 25,003 DA32 Life Science Tech Acquisition Corp shares in Q3 2023, an estimated $257K.
  • Piper Sandler & Co first reported a position in DA32 Life Science Tech Acquisition Corp in Q1 2022 and held it in 6 quarters.
  • Piper Sandler & Co's DA32 Life Science Tech Acquisition Corp position peaked at $257K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q3 2023.

Based on Piper Sandler & Co's 13F filing for Q3 2023, filed 14 Nov 2023.